Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Retraction: characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma.
Stevenson M, Mostertz W, Acharya CR, Kim W, Walters K, Barry W, Higgins K, Tuchman SA, Crawford J, Vlahovic G, Ready N, Onaitis M, Potti A. Stevenson M, et al. Clin Cancer Res. 2012 Mar 15;18(6):1818. doi: 10.1158/1078-0432.CCR-12-0337. Epub 2012 Feb 21. Clin Cancer Res. 2012. PMID: 22355011 No abstract available.
Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer.
Hsu DS, Acharya CR, Balakumaran BS, Riedel RF, Kim MK, Stevenson M, Tuchman S, Mukherjee S, Barry W, Dressman HK, Nevins JR, Powers S, Mu D, Potti A. Hsu DS, et al. Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5312-7. doi: 10.1073/pnas.0900827106. Epub 2009 Mar 11. Proc Natl Acad Sci U S A. 2009. PMID: 19279207 Free PMC article.
Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma.
Anguiano A, Tuchman SA, Acharya C, Salter K, Gasparetto C, Zhan F, Dhodapkar M, Nevins J, Barlogie B, Shaughnessy JD Jr, Potti A. Anguiano A, et al. J Clin Oncol. 2009 Sep 1;27(25):4197-203. doi: 10.1200/JCO.2008.19.1916. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636021 Free PMC article.
Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.
Rao AV, Valk PJ, Metzeler KH, Acharya CR, Tuchman SA, Stevenson MM, Rizzieri DA, Delwel R, Buske C, Bohlander SK, Potti A, Löwenberg B. Rao AV, et al. J Clin Oncol. 2009 Nov 20;27(33):5580-6. doi: 10.1200/JCO.2009.22.2547. Epub 2009 Oct 26. J Clin Oncol. 2009. PMID: 19858393
Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma.
Tuchman SA, Bacon WA, Huang LW, Long G, Rizzieri D, Horwitz M, Chute JP, Sullivan K, Morris Engemann A, Yopp A, Li Z, Corbet K, Chao N, Gasparetto C. Tuchman SA, et al. J Clin Apher. 2015 Jun;30(3):176-82. doi: 10.1002/jca.21360. Epub 2014 Oct 8. J Clin Apher. 2015. PMID: 25293363 Free PMC article.
Quantitative measures of physical functioning after autologous hematopoietic stem cell transplantation in multiple myeloma: a feasibility study.
Tuchman SA, Lane A, Hornsby WE, Bishop C, Thomas S, Herndon JE 2nd, Long G, Gasparetto C, Jones LW. Tuchman SA, et al. Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):103-9. doi: 10.1016/j.clml.2014.09.002. Epub 2014 Sep 28. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25445473
Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma.
Huang LW, Bacon W, Cirrincione C, Peterson B, Long G, Rizzieri D, Sullivan KM, Corbet K, Horwitz M, Chao N, Gasparetto C, Tuchman SA. Huang LW, et al. Among authors: Tuchman SA. Hematol Oncol. 2017 Dec;35(4):752-759. doi: 10.1002/hon.2379. Epub 2017 Jan 19. Hematol Oncol. 2017. PMID: 28105753 Free PMC article.
28 results
Jump to page
Feedback